Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02437838 · ClinicalTrials.gov registry record
Optimizing Drug Doses in Critically Ill
A clinical trial of Traumatic Brain Injury and Kidney Functional, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 20
- Enrollment target
- 2
- Study locations
NCT02437838: Completed study of Traumatic Brain Injury and Kidney Functional, sponsored by University of North Carolina, Chapel Hill.
NCT02437838 is a study of Traumatic Brain Injury and Kidney Functional that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 20 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02437838, a study of Traumatic Brain Injury and Kidney Functional, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objectives of this study are to examine whether augmented renal clearance (ARC) compromises renally eliminated drug therapeutic serum concentrations in patients with traumatic brain injury (TBI) and to estimate the optimal dose needed to achieve therapeutic serum concentrations of the probe medication levetiracetam in patients with TBI.
Conditions Studied
Interventions
- OTHER No Intervention
Study Locations (2)
Kentucky
- University of Kentucky - Lexington
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-08 |
What the finished NCT02437838 record still lists
NCT02437838 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.
NCT02437838 reports a single indexed study location in Kentucky, North Carolina.
Frequently Asked Questions
What is clinical trial NCT02437838 about?
NCT02437838 is a clinical study titled "Optimizing Drug Doses in Critically Ill". The primary objectives of this study are to examine whether augmented renal clearance (ARC) compromises renally eliminated drug therapeutic serum concentrations in patients with traumatic brain injury (TBI) and to estimate the optimal dose needed to achieve therapeutic serum concentrations of the pr...
What is the current status of trial NCT02437838?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2015-08. Estimated completion is 2016-08.
What conditions does trial NCT02437838 study?
This clinical trial studies the following conditions: Traumatic Brain Injury, Kidney Functional.
What interventions are being tested in trial NCT02437838?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT02437838?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02437838 being conducted?
This trial has 2 study locations across Kentucky, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02437838's enrollment target sits among peer trials
20 149th of 171 higher than 21 of 171 other Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Cortical Spreading Depolarization After Severe Traumatic Brain Injury
RECRUITING
-
A Study to Evaluate the SENSE Device's Ability to Detect TBI
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia